|
End-of-day quote
Taiwan S.E.
24/09/2026
|
5-day change | 1st Jan Change | ||
| 1,155.00 TWD | -1.70% |
|
-2.12% | +172.60% |
Company Valuation: PharmaEssentia Corporation
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 78,065 | 143,840 | 114,578 | 204,725 | 173,829 | 478,669 | - | - |
| Change | - | 84.26% | -20.34% | 78.68% | -15.09% | 175.37% | - | - |
| Enterprise Value (EV) 1 | 75,148 | 133,629 | 94,995 | 183,725 | 153,423 | 452,524 | 444,427 | 478,669 |
| Change | - | 77.82% | -28.91% | 93.4% | -16.49% | 194.95% | -1.79% | 7.7% |
| P/E | -27.1x | -98.6x | -179x | 69.3x | 34.6x | 42.7x | 27x | 18.9x |
| PBR | 19.1x | 11.2x | 4.79x | 7.45x | 5.46x | 10.5x | 8.33x | - |
| PEG | - | 1.8x | 3x | -0x | 0.5x | 0x | 0.5x | 0.4x |
| Capitalization / Revenue | 119x | 49.9x | 22.4x | 21x | 11.1x | 16.9x | 11.9x | 8.89x |
| EV / Revenue | 114x | 46.4x | 18.6x | 18.9x | 9.81x | 16x | 11x | 8.89x |
| EV / EBITDA | -29x | -74.2x | -57.8x | 87.3x | 28.8x | 32.4x | 24.1x | 28.9x |
| EV / EBIT | -26.6x | -65.9x | -49.6x | 106x | 31.1x | 35.3x | 23.5x | 29.5x |
| EV / FCF | -29.7x | -73.5x | -49.8x | 102x | 41.7x | 64.2x | 43.4x | - |
| FCF Yield | -3.37% | -1.36% | -2.01% | 0.98% | 2.4% | 1.56% | 2.3% | - |
| Dividend per Share 2 | - | - | - | 0.8936 | 1.352 | 4 | 2.35 | - |
| Rate of return | - | - | - | 0.18% | 0.32% | 0.35% | 0.2% | - |
| EPS 2 | -8.773 | -3.932 | -1.568 | 7.214 | 12.25 | 27.03 | 42.82 | 61.25 |
| Distribution rate | - | - | - | 12.4% | 11% | 14.8% | 5.49% | - |
| Net sales 1 | 656.5 | 2,882 | 5,106 | 9,735 | 15,635 | 28,332 | 40,360 | 53,837 |
| EBITDA 1 | -2,595 | -1,800 | -1,645 | 2,104 | 5,327 | 13,965 | 18,433 | 16,591 |
| EBIT 1 | -2,822 | -2,028 | -1,913 | 1,736 | 4,928 | 12,821 | 18,925 | 16,243 |
| Net income 1 | -2,811 | -1,375 | -623.8 | 2,966 | 5,045 | 10,927 | 18,133 | 25,880 |
| Net Debt 1 | -2,917 | -10,211 | -19,582 | -21,000 | -20,406 | -26,145 | -34,242 | - |
| Reference price 2 | 238.02 | 387.49 | 281.07 | 499.59 | 423.70 | 1,155.00 | 1,155.00 | 1,155.00 |
| Nbr of stocks (in thousands) | 327,980 | 371,210 | 407,644 | 409,783 | 410,264 | 414,432 | - | - |
| Announcement Date | 02/03/22 | 01/03/23 | 27/02/24 | 26/02/25 | 03/03/26 | - | - | - |
1TWD in Million2TWD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 42.74x | 15.97x | 32.4x | 0.35% | 15.06B | |
| 21.09x | 7.5x | 15.07x | 1.41% | 72.26B | |
| 31.3x | 9.02x | 28.11x | 0.04% | 60.24B | |
| 32.1x | 6.85x | 17.78x | -.--% | 27.73B | |
| -72.3x | 13.87x | -75.56x | -.--% | 25.74B | |
| -15.17x | 5.73x | -7.2x | -.--% | 24.75B | |
| 28.46x | 5.35x | 17.81x | -.--% | 20.74B | |
| 17.96x | 5.35x | 12.5x | -.--% | 14.42B | |
| 1015.79x | 35.53x | 613.78x | -.--% | 14.23B | |
| -13.58x | 3053.24x | -15.63x | -.--% | 12.45B | |
| Average | 108.84x | 315.84x | 63.91x | 0.18% | 28.76B | |
| Weighted average by Cap. | 62.03x | 141.61x | 37.30x | 0.38% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- 6446 Stock
- Valuation PharmaEssentia Corporation
Select your edition
All financial news and data tailored to specific country editions
